CompletedPhase 3NCT01377467
Denosumab for Prevention of Osteoporosis in Renal Transplant Recipients
Studying Idiopathic pregnancy-associated osteoporosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Rudolf Wuethrich
- Principal Investigator
- Rudolf P Wuthrich, MDDivision of Nephrology, University Hospital, Zurich
- Intervention
- Denosumab (Prolia)(drug)
- Enrollment
- 90 target
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2011 – 2015
Study locations (1)
- Division of Nephrology, University Hospital, Zurich, Switzerland
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01377467 on ClinicalTrials.govOther trials for Idiopathic pregnancy-associated osteoporosis
Additional recruiting or active studies for the same condition.
See all trials for Idiopathic pregnancy-associated osteoporosis →